Katherine Karakoula

Dr. Katherine Karakoula is a Senior Lecturer in Pharmacy Sciences at the University of Wolverhampton’s Faculty of Science and Engineering. She holds a PhD in Cancer Biology from the University of Leicester and has a distinguished career in molecular neuro-oncology, focusing on pediatric and adult brain tumors.

• PhD in Cancer Biology (University of Leicester)
• MSc in Molecular Genetics (University of Leicester)
• BSc (Hons) in Applied Biology (De Montfort University)

Her research spans genetics and genomics of gliomas, epigenetic mechanisms in brain cancer, and metabolic therapies for malignant glioma. She collaborates with De Montfort University on drug repurposing strategies and has established the Neuro-Oncology Brain Tumour Research Centre at Wolverhampton.

Her publications highlight trends in epigenetic regulation, metabolic reprogramming, and novel therapeutic targets for brain tumors. Key areas include FGFR1 signaling, hexokinase 2 in drug resistance, and genomic deletions in pediatric cancers.

• Fellow of the Higher Education Academy (2015)

Dr. Karakoula supervises PhD, MSc, and BSc students at Wolverhampton, with past projects examining hypoxia effects, anti-angiogenic therapy resistance, and epigenetic silencing in astrocytoma. She has reviewed for journals like Drug Design, Development and Therapy and Carcinogenesis, and is a member of the British Neuro-Oncology Society.